PhnyX Lab is a Seoul– and Silicon Valley-based AI startup (launched in September 2024) offering Cheiron, the first modular RAG-powered generative AI platform for pharmaceutical R&D. Trusted by over 60 pharma companies, it streamlines drug research and medical writing workflows.